An integrated approach for deeper insight with both open and closed claims data
Pharma teams are under sharper financial scrutiny and policy pressure than they've been in years,...
Pharma teams are under sharper financial scrutiny and policy pressure than they've been in years,...
Why most syndicated healthcare audiences fall short Claims data is the foundation of any credible...
A recent CNBC article used HealthVerity real-world data (RWD) to highlight a shortage of estrogen...
In epidemiology, statistical power determines whether a study can accurately detect an effect of a...
Real World Data (RWD) is increasingly being incorporated into healthcare and life science research...
Artificial intelligence is moving quickly into healthcare research, but one question still comes...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Why healthcare marketers need more transparency in audience targeting Healthcare marketers are...
In Season 2 of The Pitt, Dr. Santos accepts an AI-drafted clinical note and moves on. It’s one of...
When our client, a global pharmaceutical company, set out to better understand long COVID pathways,...
Pharma teams are under sharper financial scrutiny and policy pressure than they've been in years, and the decisions being asked of them (pricing, access, launch strategy, lifecycle planning) all hinge on a comprehensive patient journey.